Cargando…
Association of Glycolysis-Enhancing α-1 Blockers With Risk of Developing Parkinson Disease
IMPORTANCE: Parkinson disease (PD) is a common neurodegenerative disease. A treatment that prevents or delays development of PD is a critical unmet need. Terazosin and closely related drugs were recently discovered to enhance glycolysis and reduce PD progression in animal models and human clinical d...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
American Medical Association
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7851758/ https://www.ncbi.nlm.nih.gov/pubmed/33523098 http://dx.doi.org/10.1001/jamaneurol.2020.5157 |